Otezla can be used to treat plaque psoriasis of any severity in adults. Clinical studies show that Otezla is an effective treatment for adults with mild, moderate, or severe plaque psoriasis.

Mild side effects of Otezla can include ... For treatment of plaque psoriasis in adults, Otezla is usually taken twice per day. You’ll likely take the drug once in the morning and once in ...

Otezla may cause mild side effects other than the ones listed ... Otezla is approved for the treatment of moderate to severe plaque psoriasis in children ages 6 years and older.

The latest FDA approval was based on the results of the ADVANCE trial, which showed that five times as many adults with mild to moderate plaque psoriasis receiving oral Otezla 30 mg twice daily ...

To treat mild guttate psoriasis, you can use ... Some options include acitretin (Soriatane) capsules, apremilast (Otezla) oral tablets, deucravacitinib (Sotyktu) oral TYK 2 inhibitor, or ...

For example, a study of apremilast (Otezla) in palmoplantar pustulosis ... a recent study of apremilast in patients with mild/moderate plaque psoriasis that had not responded to one or more ...

Amgen maintains that Otezla remains the only approved oral systemic therapy with a broad indication and is “well positioned” to help the 4 million US patients with mild to moderate psoriasis ...

Otezla is the first oral therapy approved for moderate to severe plaque psoriasis in this patient population. The Food and Drug Administration (FDA) has expanded the approval of Otezla ...

Amgen (NASDAQ:AMGN) today announced Otezla® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Otezla for the ...

It also highlighted that Apremilast Accord is a generic of Otezla, which has been ... that that five times as many adults with mild-to-moderate plaque psoriasis achieved a Static Physician's ...